HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.

Abstract
This is the first study evaluating the clinical, metabolic, and hormonal effects of the ethinylestradiol-chlormadinone acetate (EECMA) combination in hirsute women with polycystic ovary syndrome (PCOS). Ultrasonographic pelvic examination, hirsutism score, and hormone profile evaluation were performed at baseline and after 3 and 6 cycles of treatment. Oral glucose tolerance test, euglycemic-hyperinsulinemic clamp, and assessment of lipid profile were carried out at baseline and after 6 cycles of treatment. A significant improvement in hirsutism was evident at the end of treatment. From the third cycle onward, plasma levels of sex hormone binding globulin significantly increased when compared to baseline. Free androgen index, androstenedione, and 17-hydroxyprogesterone significantly decreased after 6 cycles. The treatment did not affect glucose and insulin homeostasis. Total cholesterol, triglycerides, and high-density lipoprotein (HDL) plasma levels remained unvaried, whereas low-density lipoprotein (LDL) concentrations showed a significant reduction. A significant increase in very-low-density lipoprotein (VLDL) levels was seen at the sixth cycle of therapy. In conclusion, EE-CMA combination ameliorates clinical and hormonal features of PCOS women, with no detrimental effects on glucose, insulin, and lipid metabolism.
AuthorsMaurizio Guido, Daniela Romualdi, Giuseppe Campagna, Luigi Ricciardi, Alessandro Bompiani, Antonio Lanzone
JournalReproductive sciences (Thousand Oaks, Calif.) (Reprod Sci) Vol. 17 Issue 8 Pg. 767-75 (Aug 2010) ISSN: 1933-7205 [Electronic] United States
PMID20595709 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Contraceptives, Oral, Combined
  • Lipids
  • ethinylestradiol-chlormadinone acetate
  • Chlormadinone Acetate
  • Ethinyl Estradiol
Topics
  • Adolescent
  • Adult
  • Blood Glucose (analysis)
  • Chlormadinone Acetate (adverse effects, analogs & derivatives, therapeutic use)
  • Contraceptives, Oral, Combined (adverse effects, therapeutic use)
  • Ethinyl Estradiol (adverse effects, analogs & derivatives, therapeutic use)
  • Female
  • Glucose Clamp Technique
  • Glucose Tolerance Test
  • Hirsutism (blood, drug therapy)
  • Humans
  • Lipids (blood)
  • Polycystic Ovary Syndrome (blood, physiopathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: